MPD: Measures involving rotarod

Measures involving rotarod

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Brinkmeyer1:215	Brinkmeyer1	rotarod	Theiler's murine encephalomyelitis virus	time to fall from accelerating rotarod, post infection wk 7 [s] rotarod 64615 trial 1 trial 2 trial 3 trial 4 trial 5 trial 6 trial 7 trial 8 trial 9	CC	5	both	4wks	N=2	2017

Brown2:61	Brown2	rotarod	(none)	latency to fall from accelerating rotarod (8 rpm/min) [s] fall_ave 22561 day1 day2 day3 day4 day5 day6 day7	inbred	12	both	10-18wks	N=12	2004

Chesler6:2	Chesler6	rotarod	(none)	latency to fall, initial trial [s] Rotarod_base 27102	QTL population		both	9-34wks	N=186	2012

Chesler6:3	Chesler6	rotarod	(none)	latency difference, final minus initial trial latency to fall on rotarod through 10 training trials [s] Rotarod_learn 27103	QTL population		both	9-34wks	N=186	2012

Chesler6:4	Chesler6	rotarod	ethanol	latency difference, two trial post alcohol average minus pre trial latency to fall off rotarod [s] Rotarod_atax 27104	QTL population		both	9-34wks	N=186	2012

Chesler6:8	Chesler6	rotarod	(none)	average latency to fall over 10 training trials [second] Avg1to10 27108	QTL population		both	9-34wks	N=186	2012

Chesler6:9	Chesler6	rotarod	ethanol	latency to fall, first alcohol trial [s] RotaTest1 27109	QTL population		both	9-34wks	N=186	2012

Crabbe2:19	Crabbe2	rotarod	diazepam	latency to fall from 5 rpm rotarod, 0 min post-injection [s] fall_DZ20 15519 trial block1 trial block2	inbred	15	m	6-7wks	N=13	1998

Crabbe3:10	Crabbe3	rotarod	ethanol	latency to fall, fixed speed 3 rpm rotarod [s] FS_3rpm_EtOH 15810 dose (g/kg): 1 2 3	inbred	9	both	9-17wks	N=4	2003

Crabbe3:15	Crabbe3	rotarod	ethanol	latency to fall, fixed speed 6 rpm rotarod [s] FS_6rpm_EtOH 15815 dose (g/kg) 1 2 3	inbred	9	both	9-17wks	N=3	2003

Crabbe3:20	Crabbe3	rotarod	ethanol	latency to fall, fixed speed 10 rpm rotarod [s] FS_10rpm_EtOH 15820 dose (g/kg): 1 2 3	inbred	9	both	9-17wks	N=3	2003

Crabbe3:30	Crabbe3	rotarod	(none)	accelerating rotarod (ARR1) acquisition trial average over all trials (20 rpm/min) [s] ARR1_performance 15830	inbred	8	both	9-17wks	N=6	2003

Crabbe3:31	Crabbe3	rotarod	(none)	accelerating rotarod (ARR1) acquisition trial average of last 3 trials minus average of first 3 trials (20 rpm/min) [s] ARR1_improvement 15831	inbred	8	both	9-17wks	N=6	2003

Crabbe3:40	Crabbe3	rotarod	ethanol	latency to-fall, accelerating rotarod, test day 1 20 rpm/min (ARR1) [s] ARR1_20rpm 15840 baseline ethanol difference	inbred	8	both	9-17wks	N=6	2003

Crabbe3:45	Crabbe3	rotarod	ethanol	latency to-fall, accelerating rotarod, test day 2 30 rpm/min (ARR1) [s] ARR1_30rpm 15845 baseline ethanol difference	inbred	8	both	9-17wks	N=6	2003

Crabbe3:50	Crabbe3	rotarod	(none)	accelerating rotarod (ARR2) acquisition trial average over all trials (20 rpm/min) [s] ARR2_performance 15850	inbred	21	both	9-17wks	N=9	2003

Crabbe3:51	Crabbe3	rotarod	(none)	accelerating rotarod (ARR2) acquisition trial average of first 2 trials minus average of last 2 trials (20 rpm/min) [s] ARR2_improvement 15851	inbred	21	both	9-17wks	N=9	2003

Crabbe3:55	Crabbe3	rotarod	ethanol	latency to fall, accelerating rotarod, 20 rpm/min (ARR2) [s] ARR2_20rpm 15855 baseline ethanol	inbred	21	both	9-17wks	N=9	2003

Crabbe3:57	Crabbe3	rotarod	ethanol	average latency to fall, accelerating rotarod, 20 rpm/min (ARR2), post-injection trials minus pre-injection trials (ETPOST - ETBASE) [s] ARR2_chg_20rpm 15857	inbred	21	both	9-17wks	N=9	2003

Crabbe3:58	Crabbe3	rotarod	(none)	average latency to fall, accelerating rotarod, 20 rpm/min (ARR2), post-injection saline control minus pre-injection saline control (SALPOST - SALBASE) [s] ARR2_chg_20rpm_saline 15858	inbred	21	both	9-17wks	N=9	2003

GMC04:11	GMC04	rotarod	(none)	latency to fall from accelerating rotarod (8rpm/min) [s] LatFall 55311 trial1 trial2 trial3	inbred w/CC7	7	both	9-10wks	N=17	2018

GMC04:15	GMC04	rotarod	(none)	latency to fall from accelerating (8rpm/min) rotarod, mean of trials [s] LatFall_mean 55315	inbred w/CC7	7	both	9-10wks	N=17	2018

JaxCC1:9139	JaxCC1	rotarod	(none)	duration [s] duration 89139	CC	18	both	10-12wks	N=7	2018

JaxCC1:9141	JaxCC1	rotarod	(none)	mean duration on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] duration_rota 89141	CC	18	both	10-12wks	N=7	2018

JaxCC1:9142	JaxCC1	rotarod	(none)	learning difference on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] learn_diff_rota 89142	CC	18	both	10-12wks	N=7	2018

JaxCC1:9143	JaxCC1	rotarod	(none)	learning slope on accelerating rotarod (4-40 rpm/5 min) over 5 trials learn_slope_rota 89143	CC	18	both	10-12wks	N=7	2018

JaxKOMP-EAP:238	JaxKOMP-EAP	rotarod	(none)	trial number [n] trial_rota trial 100589 categorical	KOMP	598	both	11wks		2016

JaxKOMP-EAP:239	JaxKOMP-EAP	rotarod	(none)	mean latency to fall off accelerating rotarod (4-40 rpm/ 5 min) over 5 trials [s] latency_rota duration 100590	KOMP	557	both	11wks	N=10	2016

JaxKOMP-EAP:240	JaxKOMP-EAP	rotarod	(none)	outcome of accelerating rotarod (4-40 rpm/ 5 min) over 5 trials outcome_rota outcome 100591 categorical	KOMP	598	both	11wks		2016

JaxKOMP-EAP:241	JaxKOMP-EAP	rotarod	(none)	mean duration on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] duration_rota average_duration 100592	KOMP	557	both	11wks	N=10	2016

JaxKOMP-EAP:242	JaxKOMP-EAP	rotarod	(none)	learning difference on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] learn_diff_rota learning_difference 100593	KOMP	557	both	11wks	N=10	2016

JaxKOMP-EAP:243	JaxKOMP-EAP	rotarod	(none)	learning slope on accelerating rotarod (4-40 rpm/5 min) over 5 trials [] learn_slope_rota learning_slope 100594	KOMP	557	both	11wks	N=10	2016

Jaxpheno7:43	Jaxpheno7	rotarod	(none)	latency to fall from stationary rotarod during habituation period [s] latency_stationary 34943 trial1 trial2 trial3 average	inbred	6	m	10wks	N=7	2010

Jaxpheno7:47	Jaxpheno7	rotarod	(none)	latency to fall from rotarod at constant 4 rpm [s] latency_constant 34947 trial1 trial2 trial3 average	inbred	6	m	10wks	N=7	2010

Jaxpheno7:51	Jaxpheno7	rotarod	(none)	latency to fall from accelerating rotarod, 6 rpm/min [s] latency_accel 34951 trial1 trial2 trial3 average	inbred	6	m	10wks	N=8	2010

Jaxpheno7:55	Jaxpheno7	rotarod	(none)	peak acceleration on the rotarod prior to fall, 0.1 rpm/s [s] peak_rpm 34955 trial1 trial2 trial3 average	inbred	6	m	10wks	N=8	2010

Lake3:15	Lake3	rotarod	(none)	rotarod habituation, latency to fall from stationary rotarod [s] stationary 19015 trial1 trial2 trial3	B6.A consomic w/par	23	both	8-9wks	N=8	2005

Lake3:18	Lake3	rotarod	(none)	latency to fall from 4 rpm rotarod [s] constant 19018 trial1 trial2 trial3	B6.A consomic w/par	23	both	8-9wks	N=8	2005

Lake3:21	Lake3	rotarod	(none)	latency to fall from accelerating rotarod, 60 rpm/min [s] accel 19021 trial1 trial2 trial3	B6.A consomic w/par	23	both	8-9wks	N=8	2005

Mao1:11	Mao1	rotarod	(none)	speed prior to falling off of accelerating rotarod, 20 rpm/min [n/min] speed 54111	CC	16	both	10wks	N=11	2015

Other available data sets:

Data set	Procedure	What's in this data set	Panel	Sex	Age (weeks)	Year
ITP1	rotarod with (R/S)-1,3-butanediol, 17-a-estradiol, 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride, 2-(2-Hydroxyphenyl)benzoxazole, 3-(3-hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one, 4-OH-a-phenyl-N-tert-butyl nitrone, 4-phenylbutyrate, acarbose, aspirin, astaxanthin, b-guanidinopropionic acid, caffeic acid phenethyl ester, canagliflozin, captopril, candesartan cilexetil, curcumin, dimethyl fumarate, enalapril, fisetin, fish oil, geranylgeranyl acetone, glycine, green tea extract, INT-767 FXR/TGR5 agonist, inulin, L-Leucine, meclizine, medium-chain triglyceride, metformin, metformin plus rapamycin, methylene blue, minocycline, MitoQ, mycophenolic acid, nicotinamide riboside, nitroflurbiprofen, nordihydroguaiaretic acid, oxaloacetic acid, PB125, protandim, rapamycin, rapamycin plus acarbose, resveratrol, SG1002, simvastatin, sulindac, syringaresinol, TM5441, ursodeoxycholic acid, ursolic acid, 16-a-hydroxyestriol, 2,4-dinitrophenol, a-Ketoglutarate, Hydralazine, Nebivolol, Sodium thiosulfate	Interventions vs. controls.	UM-HET3 population	both	various	2004-2024

Filter Table Results